Mumps, including avohilmo

AB1_MUMPS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — B26 Hospital discharge: ICD-10 — B26 Hospital discharge: ICD-9 — 07[2] Hospital discharge: ICD-8 — 07[2] Cause of death: ICD-10 — B26 Cause of death: ICD-9 — 07[2] Cause of death: ICD-8 — 07[2] 3 out of 7 registries used, show all original rules.	1036
4. Check minimum number of events None	1036
5. Include endpoints None	1036
6. Filter based on genotype QC (FinnGen only)	1021

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_VIRAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_MUMPS_WIDE
CONTROL_EXCLUDE	AB1_OTHER_VIRAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	B26
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B26
HD_ICD_9	07[2]
HD_ICD_8	07[2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B26
COD_ICD_9	07[2]
COD_ICD_8	07[2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mumps, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Mumps

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1021	493	528
Unadjusted period prevalence (%)	0.21	0.18	0.24
Median age at first event (years)	15.76	17.51	14.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1036: Matched controls
10360

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

07201

ICD-8 Finland

Mumps, Cum meningoencephalitide

+∞

307.7

528

07209

ICD-8 Finland

Mumps, Unspecified

+∞

151.9

142

07202

ICD-8 Finland

Mumps, Cum orchitide

+∞

130.0

122

B26.9

ICD-10 Finland

Mumps without complication

+∞

86.7

07207

ICD-8 Finland

Mumps, Suspecta

+∞

68.5

07200

ICD-8 Finland

Mumps, Cum pancreatitide

+∞

68.5

07206

ICD-8 Finland

Mumps, Cum complicatione alia

+∞

26.2

K11.2

ICD-10 Finland

Sialoadenitis

4.5

25.1

143

B26

ICD-10 Finland

Mumps

+∞

14.6

B34.9

ICD-10 Finland

Viral infection, unspecified

5.5

14.1

B26.0

ICD-10 Finland

Mumps orchitis

+∞

11.5

B26.8

ICD-10 Finland

Mumps with other complications

+∞

9.4

07997

ICD-8 Finland

Other viral diseases, Viroses suspectae

+∞

9.4

0729X

ICD-9 Finland

Mumps without mention of complication

+∞

9.4

07999

ICD-8 Finland

Other viral diseases, Viral infection, unspecified

+∞

8.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

8.3

361

2728

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.5

8.2

217

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.5

7.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

7.6

194

D82

ICPC

Teeth/gum disease

1.4

7.0

376

2938

SFA10

NOMESCO Finland

One-surface restoration

1.4

6.7

557

4692

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

6.7

447

3626

S02.59

ICD-10 Finland

Tooth fracture UNS

2.9

6.4

102

J01DB01

ATC

cefalexin; oral

1.5

6.2

830

7552

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Otolaryngology
4 [38004449]

2.7e-01

6.0e-01

2.1e+00

1.0e+50

4.3e+00

2.4e+00

8.6e-01

cases:9.86%

controls:7.73%

cases:4.93%

controls:2.77%

cases:4.93%

controls:0.66%

cases:35.21%

controls:0.00%

cases:21.83%

controls:0.36%

cases:22.70%

controls:2.72%

cases:17.52%

controls:8.28%

106

128

1265

135

1333

135

1362

1371

111

1366

109

1324

110

113

1219

Outpatient Visit
OP [9202]

3.0e-01

2.1e-01

5.7e-01

3.3e+00

1.6e+00

7.4e-01

4.9e-01

cases:52.11%

controls:44.71%

cases:35.21%

controls:30.63%

cases:12.68%

controls:7.59%

cases:11.97%

controls:0.51%

cases:26.76%

controls:6.93%

cases:47.52%

controls:30.27%

cases:69.34%

controls:58.01%

613

758

420

951

104

124

1267

125

1364

104

1276

412

949

771

558

cefalexin; oral
J01DB01 [21602870]

4.4e-01

7.2e-01

2.6e+00

—

2.7e+00

5.5e-01

4.0e-01

cases:30.28%

controls:21.81%

cases:13.38%

controls:7.00%

cases:9.15%

controls:0.73%

—

cases:14.79%

controls:1.09%

cases:11.35%

controls:6.91%

cases:33.58%

controls:25.28%

299

1072

123

1275

129

1361

—

121

1356

125

1267

336

993

Emergency Room Visit
ER [9203]

5.6e-01

7.8e-01

2.8e+00

—

2.3e+00

6.9e-01

4.7e-01

cases:32.39%

controls:21.52%

cases:18.31%

controls:9.34%

cases:8.45%

controls:0.58%

—

cases:11.27%

controls:1.24%

cases:19.15%

controls:10.65%

cases:35.77%

controls:25.81%

295

1076

128

116

1243

130

1363

—

126

1354

145

114

1216

343

986

Pharmacy visit
OMOP4822462 [581458]

-6.1e-02

1.5e-01

7.5e-01

3.0e+00

9.8e-01

-2.1e-02

1.7e-02

cases:72.54%

controls:73.74%

cases:64.08%

controls:60.54%

cases:39.44%

controls:23.56%

cases:21.83%

controls:1.31%

cases:46.48%

controls:24.51%

cases:62.41%

controls:62.89%

cases:78.10%

controls:77.80%

103

1011

360

830

541

323

1048

111

1353

336

1035

856

505

107

1034

295

Inpatient Hospital
21 [8717]

3.6e-01

4.9e-01

2.3e+00

—

1.9e+00

4.7e-01

3.3e-01

cases:33.80%

controls:26.33%

cases:15.49%

controls:10.14%

cases:5.63%

controls:0.58%

—

cases:8.45%

controls:1.31%

cases:14.18%

controls:9.33%

cases:31.39%

controls:24.76%

361

1010

139

120

1232

134

1363

—

130

1353

127

121

1234

329

1000

Obesity due to excess calories
E66.01 [2000501501]

—

2.3e+00

—

cases:5.11%

controls:0.53%

—

130

1322

Internal Medicine
11 [38004456]

6.9e-01

5.8e-01

1.3e+00

1.0e+50

2.3e+00

2.6e-01

4.5e-01

cases:24.65%

controls:14.08%

cases:12.68%

controls:7.51%

cases:3.52%

controls:1.02%

cases:12.68%

controls:0.00%

cases:9.15%

controls:1.02%

cases:9.93%

controls:7.86%

cases:24.82%

controls:17.38%

193

107

1178

103

124

1268

137

1357

124

1371

129

1357

107

127

1254

231

103

1098

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

-2.5e-01

2.0e-01

1.6e+00

—

1.9e+00

6.8e-01

2.5e-01

cases:5.63%

controls:7.15%

cases:7.04%

controls:5.84%

cases:4.23%

controls:0.88%

—

cases:4.93%

controls:0.80%

cases:9.93%

controls:5.29%

cases:18.98%

controls:15.43%

134

1273

132

1291

136

1359

—

135

1360

127

1289

205

111

1124

quetiapine; oral
N05AH04 [21604544]

—

1.4e+00

—

cases:8.03%

controls:2.03%

—

126

1302

codeine and paracetamol
N02AJ06 [1123647]

3.0e-01

1.2e+00

—

1.3e+00

7.1e-01

cases:8.45%

controls:6.42%

cases:8.45%

controls:2.70%

—

cases:9.93%

controls:2.87%

cases:14.60%

controls:7.75%

130

1283

130

1334

—

127

1322

103

117

1226

Supplier / Service Provider
OMOP5117446 [33004]

-1.7e+00

-6.4e-01

—

2.9e+00

cases:7.04%

controls:30.27%

cases:5.63%

controls:10.14%

—

cases:10.22%

controls:0.60%

415

132

956

139

134

1232

—

123

1321

Scheduled procedure
ZXD10 [2001311387]

3.3e-01

—

1.1e+00

cases:3.52%

controls:2.55%

—

cases:10.95%

controls:3.99%

137

1336

—

122

1276

Fat metabolism disorder associated with chronic coronary artery disease
213 [2001600209]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

tramadol; oral, parenteral, rectal
N02AX02 [21604298]

6.5e-01

—

8.2e-01

cases:7.04%

controls:3.79%

—

cases:10.95%

controls:5.12%

132

1319

—

122

1261

naproxcinod
M01AE18 [40254094]

4.9e-01

—

-1.0e+50

—

-4.4e-02

cases:13.38%

controls:8.68%

—

cases:0.00%

controls:0.51%

—

cases:7.30%

controls:7.60%

119

123

1252

—

142

1364

—

101

127

1228

SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 [2002330114]

-1.0e+50

—

cases:0.00%

controls:4.16%

—

142

1314

—

Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Two-surface restoration
SFA20 [2001310359]

-3.2e-01

-1.0e-01

—

-1.0e+50

3.8e-01

1.2e-01

cases:5.63%

controls:7.59%

cases:4.23%

controls:4.67%

—

cases:0.00%

controls:0.80%

cases:4.96%

controls:3.45%

cases:13.14%

controls:11.81%

104

134

1267

136

1307

—

142

1360

134

1314

157

119

1172

Stress incontinence
N39.3 [45539046]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.44%

—

cases:0.00%

controls:0.53%

142

1365

—

137

1322

Periapical abscess without sinus
K04.7 [45586692]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.38%

142

1366

—

137

1324

hydrocortisone; oral, parenteral
H02AB09 [21602737]

1.3e+00

—

9.6e-01

cases:4.93%

controls:1.46%

—

cases:3.65%

controls:1.43%

135

1351

—

132

1310

betamethasone
D07AC01 [21602120]

5.0e-01

—

7.2e-01

6.1e-01

cases:5.63%

controls:3.50%

—

cases:3.55%

controls:1.76%

cases:8.76%

controls:4.97%

134

1323

—

136

1337

125

1263

Tooth plaque
K03.66 [2000502691]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.83%

142

1364

—

137

1318

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

—

7.2e-01

—

cases:8.03%

controls:4.06%

—

126

1275

Abdominal ultrasound examination
JN3AE [2001305555]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Melanocytic naevi of trunk
D22.5 [45542688]

—

-1.0e+50

—

cases:0.00%

controls:0.60%

—

137

1321

clindamycin; oral, parenteral
J01FF01 [21602985]

—

1.0e+50

—

6.0e-01

—

cases:3.52%

controls:0.00%

—

cases:5.11%

controls:2.86%

—

137

1371

—

130

1291

Chest pain, unspecified
R07.4 [45558450]

—

4.6e-01

—

cases:3.65%

controls:2.33%

—

132

1298

Maternal care for excessive fetal growth
O36.6 [45543983]

-1.0e+50

—

cases:0.00%

controls:0.51%

cases:0.00%

controls:0.36%

—

142

1364

142

1366

—

Cystoscopy
UKC02 [2001306005]

—

-1.0e+50

—

cases:0.00%

controls:0.68%

—

137

1320

Benign paroxysmal vertigo
H81.1 [45572061]

—

-1.0e+50

—

cases:0.00%

controls:0.60%

—

137

1321

methotrexate
L01BA01 [21601423]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Pap smear
SPAT1193 [2001700294]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

Essential (primary) hypertension
I10 [45591453]

-6.7e-02

4.6e-01

—

4.9e-01

-5.2e-02

cases:4.93%

controls:5.25%

cases:4.23%

controls:2.70%

—

cases:4.96%

controls:3.09%

cases:8.76%

controls:9.18%

135

1299

136

1334

—

134

1319

122

125

1207

Thorax X-ray examination outside radiological department
GD1UA [2001303652]

-1.0e+50

—

cases:0.00%

controls:0.80%

—

142

1360

—

General anesthesia, balanced
WX408 [2001310808]

—

1.2e+00

—

cases:6.57%

controls:2.11%

—

128

1301

Low back symptom/complaint
L03 [2002000628]

—

5.9e-01

—

cases:4.38%

controls:2.48%

—

131

1296

Otitis externa
H60 [45581713]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

varenicline; oral
N07BA03 [21604819]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Hand and fingers X-ray examination
ND2AA [2001307607]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

cromoglicic acid; nasal
R01AC01 [21605033]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

-1.6e-01

-1.2e-01

9.5e-01

—

1.2e+00

-6.4e-02

8.8e-02

cases:8.45%

controls:9.77%

cases:8.45%

controls:9.41%

cases:4.23%

controls:1.68%

—

cases:4.93%

controls:1.53%

cases:9.22%

controls:9.77%

cases:23.36%

controls:21.82%

134

130

1237

129

130

1242

136

1348

—

135

1350

133

128

1228

290

105

1039

Feeling anxious/nervous/tense
P01 [2002000798]

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

Contusion of lower back and pelvis
S30.0 [45549279]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

amlodipine; oral
C08CA01 [21601747]

3.0e-01

—

-1.0e+50

4.2e-01

1.0e-01

cases:3.52%

controls:2.63%

—

cases:0.00%

controls:0.44%

cases:3.55%

controls:2.35%

cases:3.65%

controls:3.31%

137

1335

—

142

1365

136

1329

132

1285

Thoracal epidural anesthesia
WX302 [2001310795]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Early examination of pregnancy
XMA20 [2001306915]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.66%

—

cases:0.00%

controls:1.73%

—

142

1362

—

137

1306

Arthropathic psoriasis
L40.5 [45557703]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

HLA-B27 [Presence]
4821-5 [3008898]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.45%

142

1366

—

137

1323

Examination and observation for unspecified reason
Z04.9 [45605102]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Proliferative diabetic retinopathy and Type 1 diabetes mellitus, With ophthalmic complications
H36.03*E10.3 [2000503982]

—

-1.0e+50

—

cases:0.00%

controls:0.75%

—

137

1319

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

—

-1.9e-01

—

cases:5.11%

controls:6.09%

—

130

1248

Alveolitis of jaws
K10.3 [45591576]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Procedure duration 90 to 119 minutes
ZXE13 [2001311404]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Inpatient Visit
IP [9201]

1.9e-01

5.6e-01

—

1.2e+00

4.9e-01

cases:9.15%

controls:7.66%

cases:3.52%

controls:2.04%

—

cases:3.55%

controls:1.10%

cases:10.95%

controls:7.00%

105

129

1266

137

1343

—

136

1346

122

1236

azathioprine; oral, parenteral
L04AX01 [21603927]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

No disease
A97 [2002000230]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.73%

cases:0.00%

controls:0.44%

—

cases:0.00%

controls:0.37%

—

142

1361

142

1365

—

141

1356

—

amitriptyline; oral, parenteral
N06AA09 [21604696]

—

-1.0e+50

1.0e+00

—

cases:0.00%

controls:0.59%

cases:4.38%

controls:1.58%

—

141

1353

131

1308

tizanidine; oral
M03BX02 [21604116]

4.4e-01

—

-1.0e+50

—

-1.1e-01

cases:14.08%

controls:9.56%

—

cases:0.00%

controls:0.36%

—

cases:10.95%

controls:12.04%

131

122

1240

—

142

1366

—

160

122

1169

Dentistry
C5 [903277]

—

1.5e+00

—

cases:3.52%

controls:0.80%

—

137

1360

—

Gas panel - Arterial blood
24336-0 [3019060]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Pruritus
L29 [45596372]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

lithium; oral
N05AN01 [21604556]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

cases:0.00%

controls:0.44%

cases:0.00%

controls:0.53%

—

142

1365

—

141

1355

137

1322

orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]

7.4e-01

—

-4.5e-02

cases:7.04%

controls:3.50%

—

cases:5.84%

controls:6.09%

132

1323

—

129

1248

Low back pain
M54.5 [45553207]

6.0e-01

—

-7.2e-02

cases:3.52%

controls:1.97%

—

cases:3.65%

controls:3.91%

137

1344

—

132

1277

Presence of aortocoronary bypass graft
Z95.1 [45556881]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.44%

cases:0.00%

controls:0.60%

142

1364

—

141

1355

137

1321

piroxicam; ointment
M02AA07 [21604043]

4.1e-01

—

-1.0e+50

2.3e-01

cases:5.63%

controls:3.79%

—

cases:0.00%

controls:1.18%

cases:3.65%

controls:2.93%

134

1319

—

141

1345

132

1290

Cystitis, unspecified
N30.9 [45606488]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

progesterone; oral, parenteral, rectal, vaginal
G03DA04 [21602542]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.44%

—

142

1364

—

141

1355

—

Pain in thoracic spine
M54.6 [45606247]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

cases:0.00%

controls:0.45%

—

141

1356

137

1323

Cathetrisation of artery
TPH07 [2001309747]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Midwife
Z3232 [2001311563]

-1.0e+50

—

cases:0.00%

controls:0.95%

—

142

1358

—

Type 1 diabetes mellitus, With ketoacidosis
E10.1 [45542735]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.66%

—

cases:0.00%

controls:0.53%

142

1362

—

137

1322

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

-3.7e-02

2.0e+00

—

-3.1e-01

1.6e-01

cases:4.23%

controls:4.38%

cases:4.93%

controls:5.11%

cases:3.52%

controls:0.51%

—

cases:3.55%

controls:4.78%

cases:14.60%

controls:12.72%

136

1311

135

1301

137

1364

—

136

1296

169

117

1160

Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]

—

1.5e-01

—

cases:3.65%

controls:3.16%

—

132

1287

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

—

6.1e-01

—

4.1e-01

—

cases:4.23%

controls:2.33%

—

cases:6.57%

controls:4.44%

—

136

1339

—

128

1270

combinations of corticosteroids
D07XB30 [21602188]

5.5e-01

2.9e-01

-1.0e+50

—

2.2e-01

1.3e-01

cases:11.97%

controls:7.29%

cases:4.23%

controls:3.21%

cases:0.00%

controls:0.44%

—

cases:3.55%

controls:2.87%

cases:10.95%

controls:9.71%

100

125

1271

136

1327

142

1365

—

136

1322

129

122

1200

dexbrompheniramine, combinations
R06AB56 [21603469]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Chronic ischaemic heart disease, unspecified
I25.9 [45552784]

—

-1.0e+50

—

cases:0.00%

controls:0.68%

—

137

1320

Plain photography of ocular fundus
CK2S4 [2001301455]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

dexamethasone
D07AB19 [21602116]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

sulfamethoxazole and trimethoprim
J01EE01 [21602961]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

Glucose tolerance 2 hours panel - Serum or Plasma
72171-2 [43054914]

-1.0e+50

—

cases:0.00%

controls:0.80%

—

142

1360

—

Acute vaginitis
N76.0 [45543891]

-1.0e+50

—

cases:0.00%

controls:0.58%

—

142

1363

—

Breast Pathology biopsy report
66110-8 [40768793]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Examination of eyes and vision
Z01.0 [45566391]

—

-1.0e+50

—

-1.0e+50

7.2e-01

—

cases:0.00%

controls:0.73%

—

cases:0.00%

controls:0.73%

cases:3.65%

controls:1.81%

—

142

1361

—

141

1351

132

1305

Hypertension uncomplicated
K86 [2002000613]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Ultrasound screening of fetal nuchal translucency
MA2JE [2001306837]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.88%

—

cases:0.00%

controls:0.98%

142

1359

—

137

1316

Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]

-3.7e-02

—

9.0e-01

-1.2e-01

cases:4.93%

controls:5.11%

—

cases:3.55%

controls:1.47%

cases:5.84%

controls:6.55%

135

1301

—

136

1341

129

1242

Spacing, abnormal of tooth or teeth
K07.30 [2000502776]

—

-1.0e+50

—

cases:0.00%

controls:0.60%

—

137

1321

Supervision of normal pregnancy, unspecified
Z34.9 [45566420]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Basal cell carcinoma, NOS, of skin, NOS
8090/3-C44.9 [44505057]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Acute pharyngitis, unspecified
J02.9 [45538472]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

rosuvastatin; oral
C10AA07 [21601862]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.17%

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.66%

cases:0.00%

controls:1.32%

—

142

1355

142

1366

—

142

1362

141

1343

—

Root filling of tooth with one root canal
SGB10 [2001310388]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.37%

—

142

1366

—

141

1356

—

desonide
D07AB08 [21602112]

—

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

fluticasone furoate; nasal
R01AD12 [21605053]

2.8e-01

—

-1.0e+50

6.9e-01

6.0e-01

cases:8.45%

controls:6.49%

—

cases:0.00%

controls:0.36%

cases:5.67%

controls:2.94%

cases:10.22%

controls:5.87%

130

1282

—

142

1366

133

1321

123

1251

carvedilol; oral
C07AG02 [21601700]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

cases:0.00%

controls:0.37%

cases:0.00%

controls:0.60%

—

142

1365

—

141

1356

137

1321

Dorsalgia
M54 [45553203]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

fusidic acid
D09AA02 [21602265]

—

-1.0e+50

—

6.5e-01

—

cases:0.00%

controls:0.66%

—

cases:4.38%

controls:2.33%

—

142

1362

—

131

1298

sertraline; oral
N06AB06 [21604714]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

141

1355

—

combinations of corticosteroids
D07AB30 [21602118]

5.5e-01

2.9e-01

-1.0e+50

—

2.2e-01

1.3e-01

cases:11.97%

controls:7.29%

cases:4.23%

controls:3.21%

cases:0.00%

controls:0.44%

—

cases:3.55%

controls:2.87%

cases:10.95%

controls:9.71%

100

125

1271

136

1327

142

1365

—

136

1322

129

122

1200

Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]

—

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

Physiotherapy
R4110 [2001310233]

—

8.5e-01

—

cases:5.11%

controls:2.26%

—

130

1299

loperamide; oral
A07DA03 [21600646]

—

1.9e+00

—

cases:4.38%

controls:0.68%

—

131

1320

insulin detemir; parenteral
A10AE05 [21600740]

—

-1.0e+50

—

5.5e-02

—

cases:0.00%

controls:0.51%

—

cases:3.65%

controls:3.46%

—

142

1364

—

132

1283

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

—

7.5e-01

—

cases:4.38%

controls:2.11%

—

131

1301

Heart failure, unspecified
I50.9 [45576879]

—

-1.0e+50

—

cases:0.00%

controls:0.68%

—

137

1320

levofloxacin
S01AE05 [43534860]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Other specified local infections of skin and subcutaneous tissue
L08.8 [45601211]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Sialoadenitis
K11.2 [45586705]

—

1.0e+50

—

cases:7.04%

controls:0.00%

cases:11.27%

controls:0.00%

cases:9.22%

controls:0.00%

—

132

1371

126

1371

128

1361

—

hydroxychloroquine; oral
P01BA02 [21604889]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

estriol; oral, parenteral, vaginal
G03CA04 [21602518]

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]

—

6.4e-01

—

cases:3.65%

controls:1.96%

—

132

1303

More than three and less than five hours
ZXE20 [2001311408]

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Cough
R05 [45606792]

—

1.3e+00

—

cases:3.65%

controls:0.98%

—

132

1316

Bacteria identified in Blood by Culture
600-7 [3023368]

—

-1.0e+50

1.2e+00

—

cases:0.00%

controls:0.51%

cases:4.38%

controls:1.35%

—

141

1354

131

1311

ethinylestradiol; oral
L02AA03 [21603817]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Pain localized to other parts of lower abdomen
R10.3 [45534426]

—

6.0e-01

—

cases:5.11%

controls:2.86%

—

130

1291

Right side
ZXA00 [2001311346]

—

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

Albumin [Mass/time] in Urine collected for unspecified duration
49002-9 [3050449]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.37%

—

142

1366

—

141

1356

—

Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]

-1.0e+50

—

cases:0.00%

controls:0.88%

—

142

1359

—

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

—

4.5e-02

—

cases:7.30%

controls:7.00%

—

127

1236

candesartan; oral
C09CA06 [21601829]

8.0e-01

—

3.1e-01

cases:3.52%

controls:1.60%

—

cases:3.65%

controls:2.71%

137

1349

—

132

1293

Psoriasis vulgaris
L40.0 [45543370]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.44%

—

cases:0.00%

controls:0.45%

142

1365

—

137

1323

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

—

3.0e-01

—

6.0e-01

4.5e-01

—

cases:3.52%

controls:2.63%

—

cases:3.55%

controls:1.98%

cases:6.57%

controls:4.29%

—

137

1335

—

136

1334

128

1272

Polysomnography panel
90568-7 [1002224]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

4.6e-01

—

1.3e+00

7.2e-01

cases:3.52%

controls:2.26%

—

cases:3.55%

controls:0.96%

cases:8.03%

controls:4.06%

137

1340

—

136

1348

126

1275

insulin (beef); parenteral
A10AD02 [21600730]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.88%

—

cases:0.00%

controls:0.44%

—

142

1359

—

142

1365

—

Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Removal of fixed intravenous catheter
TPH90 [2001309607]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

ipratropium bromide; inhalant
R03BB01 [21603293]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Moderate depressive episode without somatic syndrome
F32.10 [2000501980]

—

-1.0e+50

1.6e+00

—

cases:0.00%

controls:0.37%

cases:3.65%

controls:0.75%

—

141

1356

132

1319

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

5.9e-03

3.9e-01

—

7.5e-01

5.3e-01

cases:3.52%

controls:3.50%

cases:3.52%

controls:2.41%

—

cases:4.26%

controls:2.06%

cases:7.30%

controls:4.44%

137

1323

137

1338

—

135

1333

127

1270

covid-19, RNA-based vaccine
J07BN01 [954934]

—

5.2e-01

—

-1.4e-01

—

cases:3.52%

controls:2.12%

—

cases:6.57%

controls:7.45%

—

137

1342

—

128

1230

Other primary coxarthrosis
M16.1 [45591741]

-1.0e+50

—

cases:0.00%

controls:0.58%

—

142

1363

—

Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
96119-3 [36032419]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

aciclovir; oral, parenteral
J05AB01 [21603131]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]

—

-1.0e+50

6.5e-01

—

cases:0.00%

controls:0.66%

cases:4.38%

controls:2.33%

—

141

1352

131

1298

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

—

5.9e-01

—

cases:9.49%

controls:5.49%

—

124

1256

hydrocortisone
A07EA02 [21600654]

1.3e-01

—

3.4e-02

cases:6.34%

controls:5.62%

—

cases:7.30%

controls:7.07%

133

1294

—

127

1235

Eosinophils [#/volume] in Blood
26449-9 [3013115]

—

5.8e-01

—

6.0e-01

4.6e-01

—

cases:4.23%

controls:2.41%

—

cases:3.55%

controls:1.98%

cases:7.30%

controls:4.74%

—

136

1338

—

136

1334

127

1266

androstanolone
G03BB02 [21602513]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

Eyelid symptom/complaint
F16 [2002000407]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Stomatognathic treatment, basic
SHA02 [2001310406]

—

-1.0e+50

—

cases:0.00%

controls:0.90%

—

137

1317

Intramuscular and subcutaneous injection
SPAT1256 [2001700357]

—

1.8e-01

—

cases:4.38%

controls:3.69%

—

131

1280

diclofenac; ointment
M02AA15 [21604051]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

Hand/finger symptom/complaint
L12 [2002000636]

—

-1.0e+50

—

1.3e+00

—

cases:0.00%

controls:0.36%

—

cases:4.38%

controls:1.20%

—

142

1366

—

131

1313

Hyperemia of pulp
K04.00 [2000502702]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Back syndrome without radiat pain
L84 [2002000703]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Dorsalgia, unspecified
M54.9 [45538791]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

Opening and preparing the root canals, extremely complicated And time consuming
SGA05 [2001310383]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: quitter
SMOKING-2-2-3 [2002330111]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Cough
R05 [2002000886]

—

1.0e+00

—

cases:5.84%

controls:2.18%

—

129

1300

Gastroenterology
10 [38004455]

1.0e+00

—

5.7e-01

cases:3.52%

controls:1.31%

—

cases:5.84%

controls:3.39%

137

1353

—

129

1284

Telehealth
OMOP5556618 [722455]

3.5e-01

-1.3e-03

—

1.6e+00

8.7e-01

4.8e-01

cases:13.38%

controls:9.85%

cases:6.34%

controls:6.35%

—

cases:3.52%

controls:0.73%

cases:13.48%

controls:6.10%

cases:20.44%

controls:13.77%

135

123

1236

133

1284

—

137

1361

122

1278

183

109

1146

Monitoring the use of the aid
R5140 [2001310249]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
J07CA06 [21601377]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]

—

4.6e-01

—

cases:3.65%

controls:2.33%

—

132

1298

Demanding periodontal treatment
SDA04 [2001310329]

—

-1.0e+50

—

4.4e-01

—

cases:0.00%

controls:0.36%

—

cases:4.38%

controls:2.86%

—

142

1366

—

131

1291

macrogol; oral
A06AD15 [21600575]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]

—

-1.0e+50

—

cases:0.00%

controls:1.43%

—

137

1310

Routine postpartum follow-up
Z39.2 [45547306]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.37%

—

142

1366

—

141

1356

—

zolpidem; oral
N05CF02 [21604655]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

dextromethorphan; oral
R05DA09 [21603404]

2.5e-01

—

-1.0e+50

—

cases:3.52%

controls:2.77%

—

cases:0.00%

controls:0.81%

—

137

1333

—

141

1350

—

Vacuum extractor delivery
O81.4 [45582577]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.73%

—

cases:0.00%

controls:0.53%

142

1361

—

137

1322

Bacteria identified in Stool by Culture
625-4 [3025941]

-1.0e+50

—

cases:0.00%

controls:0.58%

—

142

1363

—

Supervision of other high-risk pregnancies
Z35.8 [45552076]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

cases:0.00%

controls:2.11%

—

141

1356

137

1301

Creatinine [Moles/volume] in Urine
14683-7 [3009508]

—

1.3e+00

—

cases:4.26%

controls:1.25%

—

135

1344

—

Paediatric neurology
421 [44777781]

—

-1.0e+50

—

cases:0.00%

controls:0.58%

—

142

1363

—

choriogonadotropin alfa; parenteral
G03GA08 [21602606]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.44%

—

142

1366

—

141

1355

—

Laboratory test
15220000 [4034850]

—

-1.0e+50

—

1.2e+00

—

cases:0.00%

controls:0.36%

—

cases:5.11%

controls:1.66%

—

142

1366

—

130

1307

Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]

2.4e-02

—

2.8e-01

2.5e-01

cases:6.34%

controls:6.20%

—

cases:6.38%

controls:4.92%

cases:17.52%

controls:14.15%

133

1286

—

132

1294

188

113

1141

Protein C actual/normal in Platelet poor plasma by Coagulation assay
27819-2 [3020287]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Removal of sutures
SPAT1153 [2001700254]

—

-1.0e+50

—

cases:0.00%

controls:0.96%

—

141

1348

—

Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
584-3 [3020321]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Physiotherapist
Z3226 [2001311560]

—

7.2e-01

—

cases:3.65%

controls:1.81%

—

132

1305

Delivery by elective caesarean section
O82.0 [45548833]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.53%

142

1364

—

137

1322

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

—

5.5e-01

—

cases:5.11%

controls:3.01%

—

130

1289

Rheumatology
66 [38004491]

—

1.4e+00

—

cases:6.57%

controls:1.66%

—

128

1307

Headache
R51.80 [2000503603]

-1.0e+50

—

cases:0.00%

controls:1.24%

—

142

1354

—

nortriptyline; oral, parenteral
N06AA10 [21604697]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Type 1 diabetes mellitus, Without complications
E10.9 [45581351]

—

-1.0e+50

—

cases:0.00%

controls:1.31%

—

142

1353

—

ketotifen
S01GX08 [21605092]

—

-1.0e+50

—

cases:0.00%

controls:0.68%

—

137

1320

Basophils [#/volume] in Blood
26444-0 [3006315]

—

4.6e-01

—

6.0e-01

5.6e-01

—

cases:3.52%

controls:2.26%

—

cases:3.55%

controls:1.98%

cases:7.30%

controls:4.29%

—

137

1340

—

136

1334

127

1272

Vertigo/dizziness
N17 [2002000728]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Preventive oral care by dental hygienist or dental assistant, restricted
SCF01 [2001310318]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

montelukast; oral
R03DC03 [21603356]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.60%

—

cases:0.00%

controls:0.73%

—

142

1349

—

141

1351

—

General Practice
1 [38004446]

5.5e-01

8.2e-01

—

1.0e+50

—

7.1e-01

4.3e-01

cases:9.15%

controls:5.47%

cases:5.63%

controls:2.55%

—

cases:3.52%

controls:0.00%

—

cases:4.26%

controls:2.13%

cases:10.95%

controls:7.37%

129

1296

134

1336

—

137

1371

—

135

1332

122

1231

Myalgia
M79.1 [45587062]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

141

1355

—

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

-1.2e-01

—

1.2e-01

cases:4.23%

controls:4.74%

—

cases:4.38%

controls:3.91%

136

1306

—

131

1277

letrozole; oral
L02BG04 [21603842]

—

-1.0e+50

—

cases:0.00%

controls:0.68%

—

137

1320

Post-traumatic stress disorder
F43.1 [45595909]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Hypothyroidism/myxoedema
T86 [2002001128]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

medroxyprogesterone; oral, parenteral
G03DA02 [21602540]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Emergency Medicine
93 [38004510]

5.7e-01

1.4e+00

—

1.0e+50

2.1e+00

1.2e+00

6.5e-01

cases:4.93%

controls:2.84%

cases:6.34%

controls:1.60%

—

cases:6.34%

controls:0.00%

cases:3.52%

controls:0.44%

cases:7.09%

controls:2.35%

cases:13.14%

controls:7.30%

135

1332

133

1349

—

133

1371

137

1365

131

1329

119

1232

Otitis media, unspecified
H66.9 [45547965]

—

-1.0e+50

—

cases:0.00%

controls:0.37%

—

141

1356

—

Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

imiquimod
D06BB10 [21602092]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Panretinal photocoagulation
CKC15 [2001301395]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Amniocentesis
MAA00 [2001306845]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.38%

142

1364

—

137

1324

dexamethasone
D10AA03 [21602286]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]

—

-1.0e+50

—

cases:0.00%

controls:0.66%

—

142

1362

—

cough suppressants and expectorants
R05FB02 [21603442]

2.5e-01

—

-1.0e+50

—

cases:3.52%

controls:2.77%

—

cases:0.00%

controls:0.81%

—

137

1333

—

141

1350

—

General and Unspecified, Clarification/discussion RFE/demand
A48 [2002000182]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Intraoral radiographic dental examination
EB1AA [2001301903]

-1.4e-01

—

-1.0e+50

—

-1.0e+50

—

-2.9e-01

cases:4.93%

controls:5.62%

—

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.58%

—

cases:7.30%

controls:9.56%

135

1294

—

142

1364

—

142

1363

—

127

1202

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

—

4.1e-01

—

3.3e-01

3.6e-01

—

cases:4.23%

controls:2.84%

—

cases:3.55%

controls:2.57%

cases:7.30%

controls:5.19%

—

136

1332

—

136

1326

127

1260

Tissue Pathology biopsy report
66121-5 [40768804]

—

4.5e-01

—

cases:6.57%

controls:4.29%

—

128

1272

Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]

7.9e-01

—

-1.3e-01

cases:4.23%

controls:1.97%

—

cases:3.65%

controls:4.14%

136

1344

—

132

1274

Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
38476-8 [3047826]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Supervision of normal first pregnancy
Z34.0 [45595500]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.24%

—

cases:0.00%

controls:0.37%

—

142

1354

—

141

1356

—

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

—

1.4e-02

—

cases:5.11%

controls:5.04%

—

130

1262

solifenacin; oral
G04BD08 [21602641]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Monitoring vital functions without anesthesia
WX000 [2001310756]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Rotator cuff syndrome
M75.1 [45596678]

1.4e+00

—

cases:3.52%

controls:0.88%

—

137

1359

—

methotrexate; oral, parenteral
L04AX03 [21603929]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Shortness of breath/dyspnoea
R02 [2002000883]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Health maint/preventive medicine
A98 [2002000231]

8.0e-02

2.0e-01

—

2.7e-01

8.9e-02

cases:12.68%

controls:11.82%

cases:11.27%

controls:9.41%

—

cases:13.48%

controls:10.58%

cases:27.01%

controls:25.28%

162

124

1209

129

126

1242

—

144

122

1217

336

100

993

MCH [Entitic mass]
28539-5 [3035941]

-2.5e-01

-1.2e-01

9.5e-01

—

1.2e+00

-5.6e-02

8.8e-02

cases:7.75%

controls:9.77%

cases:8.45%

controls:9.41%

cases:4.23%

controls:1.68%

—

cases:4.93%

controls:1.53%

cases:9.22%

controls:9.70%

cases:23.36%

controls:21.82%

134

131

1237

129

130

1242

136

1348

—

135

1350

132

128

1229

290

105

1039

Trigger finger
M65.3 [45538828]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

short-acting sulfonamides - combinations
J01EB20 [21602943]

—

-1.0e+50

—

cases:0.00%

controls:0.81%

—

141

1350

—

Memory test
SPAT1053 [2001700154]

—

-1.0e+50

—

cases:0.00%

controls:0.83%

—

137

1318

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

-2.3e-01

—

3.6e-01

2.0e-01

cases:3.52%

controls:4.38%

—

cases:4.26%

controls:3.01%

cases:9.49%

controls:7.90%

137

1311

—

135

1320

105

124

1224

cetirizine; oral
R06AE07 [21603497]

4.1e-01

1.0e+00

—

-1.0e+50

4.1e-01

7.5e-01

cases:10.56%

controls:7.29%

cases:7.04%

controls:2.70%

—

cases:0.00%

controls:0.36%

cases:4.26%

controls:2.87%

cases:13.14%

controls:6.70%

100

127

1271

132

1334

—

142

1366

135

1322

119

1240

encephalitis, tick borne, inactivated, whole virus
J07BA01 [21601331]

—

-1.0e+50

—

cases:0.00%

controls:0.60%

—

137

1321

influenza, inactivated, split virus or surface antigen
J07BB02 [21601335]

7.3e-02

-2.6e-01

—

2.2e-01

-6.5e-02

cases:4.23%

controls:3.94%

cases:3.52%

controls:4.52%

—

cases:4.96%

controls:4.04%

cases:10.22%

controls:10.84%

136

1317

137

1309

—

134

1306

144

123

1185

ethinylestradiol; oral
G03CA01 [21602516]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

—

5.6e-01

—

cases:3.65%

controls:2.11%

—

132

1301

C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30522-7 [3010156]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Neurology
13 [38004458]

6.9e-01

7.9e-01

—

1.3e+00

1.5e-01

cases:10.56%

controls:5.62%

cases:4.23%

controls:1.97%

—

cases:7.09%

controls:2.13%

cases:7.30%

controls:6.32%

127

1294

136

1344

—

131

1332

127

1245

Necrosis of pulp
K04.1 [45572186]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

disulfiram; oral
N07BB01 [21604821]

-1.0e+50

—

cases:0.00%

controls:0.80%

—

142

1360

—

Detailed ultrasound examination of fetus including color doppler method
MA2DE [2001306835]

-1.0e+50

—

cases:0.00%

controls:0.73%

—

142

1361

—

Medical examin/health eval complete
-30 [2002000101]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

mometasone; nasal
R01AD09 [21605051]

-3.8e-01

2.7e-01

-1.0e+50

—

5.6e-03

1.9e-01

cases:4.23%

controls:6.05%

cases:3.52%

controls:2.70%

cases:0.00%

controls:0.58%

—

cases:3.55%

controls:3.53%

cases:10.95%

controls:9.26%

136

1288

137

1334

142

1363

—

136

1313

123

122

1206

eletriptan; oral
N02CC06 [21604381]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.44%

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.75%

142

1365

142

1366

—

137

1319

Protein [Mass/volume] in Urine
2888-6 [3037121]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Extraction of tooth
EBA00 [2001301923]

2.2e-01

—

-3.8e-01

cases:3.52%

controls:2.84%

—

cases:3.65%

controls:5.27%

137

1332

—

132

1259

citalopram; oral, parenteral
N06AB04 [21604712]

3.8e-01

—

1.1e+00

5.8e-01

cases:4.23%

controls:2.92%

—

cases:3.55%

controls:1.25%

cases:5.11%

controls:2.93%

136

1331

—

136

1344

130

1290

Urgent procedure
ZXD05 [2001311386]

1.7e-01

—

cases:4.23%

controls:3.57%

—

136

1322

—

valsartan and amlodipine
C09DB01 [21601842]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.44%

cases:0.00%

controls:0.60%

142

1366

—

141

1355

137

1321

COVID-19, virus not identified
U07.2 [45756094]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.73%

—

142

1366

—

141

1351

—

glibenclamide; oral
A10BB01 [21600750]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Dysphagia
R13 [45573013]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Application of soft bandage
SPAT1211 [2001700312]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]

—

6.3e-01

—

cases:5.11%

controls:2.78%

—

130

1292

General Surgery
2 [38004447]

4.5e-01

-2.4e-01

—

-1.0e+50

4.0e-01

-1.1e-01

cases:21.83%

controls:15.17%

cases:3.52%

controls:4.45%

—

cases:0.00%

controls:0.58%

cases:7.09%

controls:4.85%

cases:13.87%

controls:15.27%

208

111

1163

137

1310

—

142

1363

131

1295

203

118

1126

Restoration involving the entire crown of the tooth
SFA40 [2001310361]

—

-1.0e+50

—

cases:0.00%

controls:2.18%

—

137

1300

Shoulder and humerus extensive MRI examination with high intensity magnet
NB1CG [2001307237]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Care and examination of lactating mother
Z39.1 [45595508]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Follow-up examination after unspecified treatment for other conditions
Z09.9 [45595482]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

tolfenamic acid; oral, rectal
M01AG02 [21603988]

—

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

Zoster [herpes zoster]
B02 [45552205]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Toothache NOS
K08.80 [2000502799]

-1.0e+50

—

cases:0.00%

controls:0.51%

—

142

1364

—

Other somatoform disorders
F45.8 [45600750]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.51%

—

cases:0.00%

controls:0.98%

142

1364

—

137

1316

Snapping jaw
K07.60 [2000502791]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Fractures of other parts of lower leg
S82.8 [45536135]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

-1.6e-01

-1.2e-01

9.5e-01

—

1.2e+00

-6.4e-02

5.1e-02

cases:8.45%

controls:9.77%

cases:8.45%

controls:9.41%

cases:4.23%

controls:1.68%

—

cases:4.93%

controls:1.53%

cases:9.22%

controls:9.77%

cases:22.63%

controls:21.75%

134

130

1237

129

130

1242

136

1348

—

135

1350

133

128

1228

289

106

1040

melatonin; oral
N05CH01 [21604659]

-1.0e+50

—

7.9e-01

cases:0.00%

controls:0.66%

—

cases:4.38%

controls:2.03%

142

1362

—

131

1302

roxithromycin; oral
J01FA06 [21602974]

1.2e-01

1.3e+00

—

2.2e-02

cases:4.93%

controls:4.38%

cases:4.23%

controls:1.17%

—

cases:4.38%

controls:4.29%

135

1311

136

1355

—

131

1272

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.36%

—

cases:0.00%

controls:0.37%

cases:0.00%

controls:0.60%

142

1366

—

141

1356

137

1321

aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]

—

-1.0e+50

—

cases:0.00%

controls:0.51%

—

141

1354

—

Person encountering health services in unspecified circumstances
Z76.9 [45609967]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

-7.1e-02

—

-3.3e-02

cases:4.23%

controls:4.52%

—

cases:8.03%

controls:8.28%

136

1309

—

110

126

1219

Laceration/cut
S18 [2002000983]

—

-1.0e+50

—

8.6e-01

—

cases:0.00%

controls:0.88%

—

cases:8.76%

controls:3.91%

—

142

1359

—

125

1277

Psychiatry
26 [38004469]

4.9e-01

9.5e-01

1.2e+00

—

4.6e-01

6.7e-01

cases:7.04%

controls:4.45%

cases:5.63%

controls:2.26%

cases:3.52%

controls:1.09%

—

cases:4.26%

controls:2.72%

cases:10.22%

controls:5.49%

132

1310

134

1340

137

1356

—

135

1324

123

1256

mometasone
D07AC13 [21602132]

—

-1.0e+50

—

cases:0.00%

controls:1.03%

—

141

1347

—

Constipation, unspecified
K59.09 [2000502926]

—

-1.0e+50

—

cases:0.00%

controls:0.60%

—

137

1321

triamcinolone and antiseptics
D07BB03 [21602150]

9.1e-01

—

cases:4.23%

controls:1.75%

—

136

1347

—

Laparotomy
JAH00 [2001304474]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

tadalafil; oral
G04BE08 [21602653]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Uroflowmetry
44856007 [4261340]

—

-1.0e+50

—

cases:0.00%

controls:0.58%

—

142

1363

—

pneumococcus, purified polysaccharides antigen conjugated
J07AL02 [21601313]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

Conjunctivitis, unspecified
H10.9 [45591253]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

137

1322

mupirocin; nasal
R01AX06 [21603201]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Migraine, unspecified
G43.9 [45595943]

—

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Nuclear Ab [Titer] in Serum
29953-7 [3037522]

—

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Preventive oral health care
SCA02 [2001310303]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.66%

—

cases:0.00%

controls:1.13%

142

1362

—

137

1314

Personal history of diseases of the digestive system
Z87.1 [45542474]

—

4.7e-01

—

cases:8.03%

controls:5.19%

—

126

1260

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
S46.0 [45544769]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

Sepsis, unspecified
A41.9 [45585911]

-1.0e+50

—

cases:0.00%

controls:0.44%

—

142

1365

—

triamcinolone and antiinfectives
S02CA04 [21605176]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

dipyridamole; oral, parenteral
B01AC07 [21600992]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Sprain and strain of cervical spine
S13.4 [45573197]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

Exploration of knee joint, arthroscopic
NGA30 [2001308091]

-1.0e+50

—

cases:0.00%

controls:0.36%

—

142

1366

—

Acute sinusitis
J01 [45548098]

—

-1.0e+50

—

cases:0.00%

controls:0.38%

—

137

1324

Outcome of delivery
Z37 [45581024]

-2.2e-01

—

-3.4e-01

cases:5.63%

controls:6.93%

—

cases:5.84%

controls:8.05%

134

1276

—

107

129

1222

insulin lispro; parenteral
A10AC04 [21600726]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:3.87%

cases:0.00%

controls:0.88%

—

cases:0.00%

controls:1.02%

cases:0.00%

controls:4.41%

—

142

1318

142

1359

—

142

1357

141

1301

—

FEV1 percent change
69983-5 [42868472]

—

2.1e+00

—

cases:3.65%

controls:0.45%

—

132

1323

Antenatal screening for malformation
717800004 [36713462]

—

1.5e-01

—

cases:5.11%

controls:4.44%

—

130

1270

Coloscopy
UJF32 [2001305029]

—

-1.0e+50

—

4.9e-01

—

cases:0.00%

controls:0.44%

—

cases:3.65%

controls:2.26%

—

142

1365

—

132

1299

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

-1.6e-01

-4.7e-01

—

3.0e-01

9.3e-02

cases:4.93%

controls:5.76%

cases:3.52%

controls:5.54%

—

cases:7.09%

controls:5.36%

cases:13.87%

controls:12.79%

135

1292

137

1295

—

131

1288

170

118

1159

Paraesthesia of skin
R20.2 [45568120]

—

-1.0e+50

—

cases:0.00%

controls:0.45%

—

137

1323

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761536) Microorganisms panel - Urine sediment

134

665

2.17

14.10

3.5

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

120

635

2.01

10.57

3.7

3.8

1.23

mmol/l

0.13

106

555

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

777

6947

1.47

6.66

4.0

4.2

14.44

14.61

pmol/l

1.32

726

6479

(3012501) Base excess in Blood by calculation

160

2.49

6.42

2.7

3.5

1.99

2.43

mmol/l

0.57

107

(3029937) Albumin [Presence] in Urine by Test strip

320

2515

1.39

5.49

3.6

0.00

0.01

estimate

1.15

140

856

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

743

6716

1.38

4.99

4.8

4.2

10.51

10.32

mm/h

0.13

695

6356

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

457

3850

1.33

4.90

5.9

6.6

1.21

mmol/l

0.29

419

3582

(3032080) INR in Blood by Coagulation assay

466

3959

1.32

4.63

11.6

11.5

1.18

1.19

inr

0.13

389

3227

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

546

4743

1.32

4.62

5.4

6.8

11.26

11.49

umol/l

0.21

513

4556

(3041096) Erythrocytes [Presence] in Urine by Automated

329

2662

1.35

4.56

3.0

2.9

0.00

0.01

estimate

1.35

122

721

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

761

6951

1.36

4.46

7.7

8.2

75.20

78.32

u/l

1.22

723

6647

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

409

3427

1.32

4.42

3.6

3.4

31.65

55.87

ng/l

0.69

280

2291

(3018418) pH of Serum or Plasma

318

2571

1.34

4.40

3.6

4.2

7.39

7.40

0.93

234

1813

(1616796) Gas panel - Central venous blood

190

2.09

4.39

3.3

3.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

223

1709

1.39

4.33

1.9

1.7

432.72

40544642.41

pmol/l

2.13

191

1470

(40768804) Tissue Pathology biopsy report

419

3532

1.31

4.31

1.9

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

941

8940

1.57

4.30

15.3

14.4

20.98

22.94

mg/l

1.24

816

7290

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

498

4305

1.30

4.23

7.1

7.2

1.21

mmol/l

0.51

392

3740

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

351

2899

1.32

4.15

3.2

2.6

57.15

60.92

u/l

0.61

319

2715

(3013826) Glucose [Moles/volume] in Serum or Plasma

592

5261

1.29

3.97

5.1

6.69

6.68

mmol/l

0.04

570

5034

(3013512) EKG study

353

2936

1.31

3.92

3.3

3.2

—

0.78

—

(3035350) Ketones [Presence] in Urine by Test strip

541

4759

1.29

3.90

3.4

3.5

0.01

10.69

estimate

1.82

145

925

(3021601) Nitrite [Presence] in Urine by Test strip

535

4703

1.28

3.86

3.5

0.00

estimate

0.50

144

908

(3009261) Glucose [Presence] in Urine by Test strip

542

4774

1.28

3.85

3.5

0.00

0.02

estimate

1.49

138

850

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

732

7875

0.76

3.82

17.9

18.3

333.61

333.52

g/l

0.09

732

7833

(3002179) Metamyelocytes/Leukocytes in Blood

110

759

1.50

3.74

5.3

4.8

0.44

0.60

0.44

237

(3048689) Calprotectin [Mass/mass] in Stool

161

1196

1.41

3.73

2.8

2.5

118.00

129.91

ug/g

0.26

127

976

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

239

1.88

3.70

2.0

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

746

6866

1.31

3.67

3.2

3.5

55.51

50.60

u/l

0.41

703

6572

(3017181) Myelocytes/Leukocytes in Blood

113

794

1.47

3.53

5.7

5.0

0.42

0.97

3.05

255

(3025159) Blasts/Leukocytes in Blood

110

770

1.48

3.50

5.6

5.4

0.07

0.18

0.80

199

(40768797) Stomach Pathology biopsy report

168

1272

1.38

3.48

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

119

849

1.45

3.44

3.0

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

878

8303

1.38

3.38

5.0

1.79

1.85

mu/l

0.76

818

7776

(3037467) Urinalysis macro (dipstick) panel - Urine

656

5972

1.27

3.33

4.4

4.1

—

3.34

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

334

2807

1.28

3.33

2.2

2.1

190.49

250.81

u/l

0.60

320

2681

(3021440) Promyelocytes/Leukocytes in Blood

107

754

1.47

3.30

5.9

5.1

0.06

0.17

1.27

215

(3042517) Benzodiazepines panel - Urine

8.61

3.26

1.0

1.4

—

(3009343) pH of Capillary blood

559

1.53

3.19

3.0

3.2

7.42

0.04

464

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

146

2.01

3.07

1.7

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

441

3864

1.25

3.02

4.6

5.1

36.22

36.39

g/l

0.27

411

3649

(42870588) Differential panel, method unspecified - Blood

359

3079

1.25

2.96

6.4

6.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

171

1.90

2.88

4.0

2.7

7.32

7.83

pmol/l

0.21

171

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

920

8814

1.39

2.85

14.9

13.7

85.12

84.32

ml/min/173m2

0.65

864

8176

(3022096) Basophils/Leukocytes in Blood

485

4316

1.23

2.82

7.1

6.8

0.72

0.71

0.26

460

4076

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

417

3655

1.24

2.79

3.4

3.3

0.00

0.03

estimate

2.65

118

758

(3016018) Differential panel - Cerebral spinal fluid

2.19

2.78

1.4

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

227

1855

1.29

2.77

2.8

2.5

6.25

5.16

e6/l

0.38

211

1699

(3044290) Cell count panel - Cerebral spinal fluid

197

1.80

2.70

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

2.12

2.70

1.1

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

597

5444

1.23

2.70

4.3

4.1

8.20

1723.21

e6/l

—

(3019069) Monocytes/Leukocytes in Blood

484

4324

1.22

2.66

7.2

6.8

8.89

8.87

0.07

457

4098

(3019550) Sodium [Moles/volume] in Serum or Plasma

949

9164

1.42

2.57

16.7

16.4

139.70

139.75

mmol/l

0.24

937

9013

(3019309) Folate [Moles/volume] in Red Blood Cells

159

1251

1.32

2.57

1.9

1.7

1249.10

1173.22

nmol/l

0.46

119

955

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

446

1.51

2.54

2.5

2.1

39.70

39.59

u/l

0.01

404

(3006504) Eosinophils/Leukocytes in Blood

482

4319

1.22

2.53

6.9

6.6

2.92

0.01

454

4084

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

476

1.48

2.42

2.8

3.2

1.66

1.81

mmol/l

0.18

346

(40760892) CBC W Ordered Manual Differential panel - Blood

262

2222

1.24

2.31

5.1

4.8

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

4.64

2.27

1.0

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.64

2.27

1.0

1.4

—

(3023368) Bacteria identified in Blood by Culture

271

2315

1.23

2.23

4.3

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

377

3329

1.21

2.23

2.6

3.5

31.60

33.17

u/l

0.46

359

3165

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

911

8773

1.32

2.22

6.6

6.0

39.29

39.13

mmol/mol

0.22

854

8363

(3020564) Creatinine [Moles/volume] in Serum or Plasma

990

9669

1.54

2.18

19.4

18.3

75.83

76.66

umol/l

0.65

984

9586

(3002030) Lymphocytes/Leukocytes in Blood

488

4424

1.19

2.15

6.9

6.7

28.78

28.15

0.66

467

4230

(3015377) Calcium [Moles/volume] in Serum or Plasma

339

2974

1.21

2.13

2.9

3.5

2.36

2.35

mmol/l

0.10

309

2734

(3023103) Potassium [Moles/volume] in Serum or Plasma

948

9194

1.37

2.10

17.1

16.6

3.97

mmol/l

0.06

935

9025

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

249

2123

1.23

2.08

1.3

0.68

1.67

u/ml

2.30

593

(3017509) Phencyclidine [Presence] in Urine

5.02

2.07

4.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

447

4036

1.19

2.03

13.3

10.9

0.00

e9/l

0.87

375

3325

(3017446) Testosterone [Moles/volume] in Serum or Plasma

147

1183

1.28

2.03

2.8

2.5

13.76

14.11

nmol/l

0.23

137

1098

(3013115) Eosinophils [#/volume] in Blood

534

4900

1.19

2.00

6.6

6.8

0.20

0.19

e9/l

0.08

476

4323

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.83

2.00

9.8

4.7

—

(3019225) pH of Specimen

747

1.34

2.00

4.4

4.2

7.32

7.35

0.51

553

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

730

1.35

1.99

2.6

2.3

68.69

70.55

ml/min/173m2

0.18

296

(3042631) Mycobacterium sp identified in Specimen

119

1.87

1.98

5.2

2.5

—

(4035726) Immunohistochemistry procedure

758

1.34

1.96

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

1.96

1.6

1.5

59.84

55.55

0.17

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.20

1.95

1.1

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.56

1.94

1.2

1.4

—

(3034426) Prothrombin time (PT)

2.98

1.94

1.0

1.3

27.75

29.67

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

1.90

1.91

1.2

1.7

—

(3018010) Neutrophils/Leukocytes in Blood

478

4357

1.18

1.91

6.7

6.5

56.69

56.94

0.19

456

4187

(3009508) Creatinine [Moles/volume] in Urine

356

3165

1.19

1.90

3.7

3.4

8.40

8.34

mmol/l

0.08

290

2715

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

1.77

1.90

1.3

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

446

4043

1.18

1.90

2.6

2.4

73.86

75.73

nmol/l

0.71

409

3712

(3026493) Urate [Moles/volume] in Serum or Plasma

293

2560

1.20

1.90

2.4

2.6

336.13

343.97

umol/l

0.79

268

2311

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.20

1.88

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

340

3015

1.19

1.87

4.7

4.0

12.13

8.09

mg/mmol

0.48

207

1885

(3007164) IgA [Mass/volume] in Serum or Plasma

219

1863

1.22

1.86

1.6

1.5

2.33

2.44

g/l

0.39

149

1210

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

402

1.44

1.84

2.6

2.0

—

(4024509) Urine culture

329

1.48

1.80

1.4

1.8

—

(3012516) Albumin [Mass/volume] in Urine

333

2957

1.19

1.79

3.7

3.4

51.18

45.34

mg/l

0.15

209

1910

(3009214) Lutropin [Units/volume] in Serum or Plasma

323

1.48

1.74

1.2

1.4

14.11

8.90

u/l

0.72

263

(3015736) pH of Urine

423

3843

1.17

1.71

3.0

3.2

6.03

6.13

1.00

235

2292

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

1.71

0.0

1.5

—

(3007461) Platelets [#/volume] in Blood

1006

9894

1.58

1.70

23.5

21.9

253.70

251.57

e9/l

0.52

991

9747

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

538

1.36

1.69

2.5

3.7

4.39

4.59

pmol/l

1.31

481

(3023323) Follitropin [Units/volume] in Serum or Plasma

547

1.36

1.69

1.4

25.77

30.17

iu/l

0.47

472

(3026782) Osmolality of Urine

185

1563

1.22

1.68

3.0

2.7

512.49

539.22

mosm/kgh2o

0.85

168

1371

(3035941) MCH [Entitic mass]

1006

9897

1.57

1.66

23.3

21.8

30.37

30.41

0.33

996

9818

(3045424) Erythrocytes [Presence] in Urine

428

1.40

1.66

1.9

2.2

0.00

1.84

estimate

0.51

138

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.90

1.66

1.7

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

127

1.75

1.65

2.2

3.8

1.59

1.12

0.42

117

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1006

9898

1.57

1.65

23.3

21.8

90.80

90.97

0.66

996

9819

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

105

1.82

1.63

2.2

35.32

32.51

4.43

105

(3010813) Leukocytes [#/volume] in Blood

1006

9899

1.56

1.63

23.4

22.0

6.70

6.62

e9/l

0.46

987

9722

(3026361) Erythrocytes [#/volume] in Blood

1006

9899

1.56

1.63

23.4

21.9

4.60

e12/l

0.03

988

9732

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1006

9899

1.56

1.63

23.9

22.4

41.46

41.36

0.27

995

9815

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

345

1.44

1.63

1.6

5.74

12.33

u/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

198

1.58

1.61

2.7

2.2

140.65

131.99

g/l

1.09

150

(3000963) Hemoglobin [Mass/volume] in Blood

1006

9902

1.55

1.59

23.6

22.0

138.92

138.89

g/l

0.02

996

9824

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.21

1.57

1.0

1.2

169.55

540.57

u/l

0.99

(3034860) Kappa light chains.free [Mass/volume] in Serum

248

1.51

1.57

2.5

3.6

40.56

45.68

mg/l

0.26

206

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

248

1.51

1.57

2.5

3.6

30.21

51.78

mg/l

0.81

204

(3036481) Cortisol [Moles/volume] in Serum or Plasma

113

913

1.27

1.54

2.1

2.2

339.42

368.45

nmol/l

1.07

104

863

(1002224) Polysomnography panel

681

1.30

1.52

1.1

—

(40768443) Skin Pathology biopsy report

384

1.40

1.52

1.3

—

(3001604) Monocytes [#/volume] in Blood

510

4730

1.15

1.52

6.3

6.5

0.59

0.58

e9/l

0.31

453

4104

(3013650) Neutrophils [#/volume] in Blood by Automated count

562

5249

1.15

1.52

9.1

10.1

4.12

4.04

e9/l

0.36

499

4607

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.60

1.51

1.0

—

(3014271) Vancomycin [Susceptibility]

2.60

1.51

2.7

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.60

1.51

1.4

1.3

—

(3006315) Basophils [#/volume] in Blood

510

4732

1.15

1.51

6.3

6.5

0.04

e9/l

0.65

455

4108

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

127

1047

1.24

1.47

5.0

4.7

31.28

30.83

0.17

719

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

220

1.52

1.45

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

131

1086

1.24

1.44

2.4

2.9

5.44

8.12

umol/l

3.11

107

970

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1.93

1.44

1.6

1.4

27.63

31.35

—

(3019198) Lymphocytes [#/volume] in Blood

517

4812

1.15

1.44

6.5

2.03

1.93

e9/l

0.43

465

4279

(3022145) Colonoscopy Study observation

131

1087

1.23

1.43

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

346

1.41

1.43

2.7

1.9

—

(3027008) Opiates [Presence] in Urine

372

1.39

1.42

2.3

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

454

4192

1.15

1.41

3.1

3.0

124.78

133.84

ug/l

0.36

412

3969

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.42

1.39

1.1

—

99.24

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.42

1.39

1.1

1.0

—

91.82

—

(3028300) Cannabinoids [Presence] in Urine

374

1.38

2.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

464

4298

1.14

1.36

3.4

3.1

—

(3036489) Thrombin time

341

1.40

1.36

2.3

2.1

20.29

20.98

0.63

307

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

110

901

1.25

1.36

2.2

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

178

1533

1.19

1.34

3.7

3.4

0.82

mmol/l

0.08

169

1452

(4268621) Lupus anticoagulant assay

105

1.73

1.33

1.7

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

236

2085

1.17

1.32

2.3

2.2

2.83

2.78

mg/l

0.12

197

1812

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.79

1.28

1.0

1.1

119.00

106.33

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

146

1.59

1.26

1.0

1.1

3.67

2.72

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.75

1.25

1.3

—

(3000494) Fungus identified in Specimen by Culture

136

1151

1.21

1.25

1.6

1.4

—

(3006462) Nitrate [Presence] in Urine

2.41

1.24

3.0

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

820

1.24

2.1

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

366

1.36

1.22

2.3

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.17

1.21

1.6

2.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

289

1.40

1.21

2.5

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

117

1.64

1.18

1.1

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.94

1.17

1.0

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

946

9269

1.24

1.15

5.5

5.1

4.66

4.73

mmol/l

1.47

889

8817

(4211845) Urine protein measurement

2.27

1.10

2.9

—

(3037756) Immunofixation for Serum or Plasma

160

1.51

1.10

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

629

5996

1.12

1.08

3.2

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

902

8807

1.19

1.08

5.2

4.9

5.96

5.95

mmol/l

0.08

834

8266

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

288

1.37

1.06

1.6

1.3

109.91

211.48

miu/ml

2.00

131

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.28

1.03

2.6

1.7

12.18

16.52

umol/l

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

112

950

1.20

1.03

4.3

4.7

214.75

245.22

u/l

2.15

107

907

(3045414) Leukocytes [Presence] in Urine

793

1.22

1.03

2.1

2.0

0.00

0.03

estimate

0.78

168

(4062490) Immunoglobulin typing, IgG

109

0.46

1.01

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.88

1.00

1.2

1.3

170.56

183.83

mmol/24h

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.88

1.00

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

370

1.31

1.00

2.4

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

1.58

0.97

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.86

0.96

7.8

3.1

423.10

618.48

u/ml

—

(3016879) Cocaine [Presence] in Urine

346

1.31

0.96

2.5

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

186

0.59

0.96

1.3

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

174

1.45

0.96

1.1

2.69

1.59

u/ml

0.17

(3028707) Methadone [Presence] in Urine by Screen method

141

1.50

0.95

3.6

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

165

1458

1.16

0.94

1.7

2.0

1.46

1.47

0.03

143

1291

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

217

1.39

0.94

1.2

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.72

0.93

1.3

1.4

82.25

77.34

umol/l

0.52

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.74

0.92

1.6

1.1

8.11

7.38

mm/h

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

411

1.28

0.92

2.3

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.68

0.91

4.9

4.0

—

(3037522) Nuclear Ab [Titer] in Serum

157

1387

1.16

0.90

1.3

1.4

689.03

466.40

titre

0.48

297

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

102

1.58

0.90

1.6

1.5

220.40

329.02

mu/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

576

1.23

0.89

1.5

1.6

—

(3012544) pH of Venous blood

877

0.82

0.89

4.1

3.4

7.36

7.38

1.08

502

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.87

0.87

1.3

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

952

9367

1.20

0.87

6.0

5.7

2.77

2.81

mmol/l

0.79

895

8881

(1761482) Bacteria [#/volume] in Urine by Culture

168

0.59

0.87

5.2

4.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

180

0.61

0.86

1.1

1.7

0.53

0.76

g/l

—

139

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

122

1062

1.17

0.86

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

941

9252

1.19

0.85

5.4

5.0

1.39

1.43

mmol/l

2.50

880

8758

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

904

8861

1.16

0.85

4.7

4.3

1.41

1.38

mmol/l

0.61

845

8333

(3008401) Mugwort IgE Ab [Units/volume] in Serum

171

1.41

0.83

1.1

1.43

0.95

u/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

111

0.54

0.83

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.74

0.82

2.6

1.3

126.75

145.18

nmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

258

2372

1.12

0.81

3.5

3.0

0.39

0.36

e6/l

0.07

203

1687

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

293

0.71

0.79

1.9

2.3

13.51

10.44

g/l

1.51

266

(3002032) Base excess in Venous blood by calculation

832

0.83

0.78

4.1

3.4

2.05

1.94

mmol/l

0.10

726

(3022313) Gas panel - Capillary blood

394

1.26

0.78

2.7

3.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

856

1.17

0.77

3.1

2.7

30.21

41.28

u/l

1.23

743

(3014133) Dog dander IgE Ab [Units/volume] in Serum

157

1.41

0.77

1.0

1.1

6.43

2.59

u/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

226

1.34

0.77

2.4

3.4

1.28

2.43

ratio

1.65

125

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

436

4129

1.10

0.76

1.9

1.53

1.45

mmol/l

0.68

351

3577

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.77

0.76

2.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

324

1.28

0.76

1.1

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

108

1.49

0.73

1.3

—

(40768446) Kidney Pathology biopsy report

1.85

0.73

1.6

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.64

0.73

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

1.0

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

749

1.18

0.72

2.5

2.8

11.18

10.65

g/l

0.46

692

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

204

1865

1.12

0.72

1.4

1.3

25.30

29.64

iu/ml

0.19

580

(3017732) Neutrophils [#/volume] in Blood

134

1194

1.14

0.71

3.8

3.4

4.01

5.42

e9/l

1.55

117

1058

(4198724) Urine methamphetamine measurement

1.75

0.71

6.6

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

574

0.81

0.70

10.8

11.5

1.39

1.36

0.09

569

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.71

0.70

1.1

2.7

168.14

192.05

u/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

178

1620

1.12

0.68

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

180

0.66

0.68

1.3

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

153

1.38

0.67

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

136

1.40

0.67

1.1

1.0

0.18

0.25

u/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

277

1.27

0.66

1.3

1.5

298.00

284.35

ug/g

0.15

169

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

975

9640

1.19

0.66

12.3

11.8

28.26

28.80

u/l

0.54

948

9433

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

206

1.32

0.66

1.2

1.1

1.32

1.72

u/ml

0.17

108

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

259

0.73

0.65

1.8

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.58

0.65

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

748

1.16

0.65

1.4

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.73

0.64

2.6

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.73

0.64

2.8

1.3

—

(4146454) Self-monitoring of blood glucose

1.50

0.63

2.0

2.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

155

1.36

0.63

4.0

3.6

19.19

22.64

mg/l

0.30

106

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

142

1283

1.12

0.62

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.59

0.62

1.5

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.46

0.61

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.61

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.60

0.0

1.3

—

68.55

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.60

0.0

1.7

—

1.23

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.60

0.0

1.8

—

7.51

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.51

0.60

1.5

2.1

—

(3022621) pH of Urine by Test strip

660

1.16

0.59

2.5

2.1

6.03

0.00

408

(3002523) Influenza virus A Ag [Presence] in Specimen

228

1.28

0.59

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

264

1.26

0.58

1.6

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.51

0.58

1.0

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

62.18

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

186

1714

1.10

0.58

1.3

5.78

12.29

u/ml

0.95

707

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

115

0.61

0.58

2.6

2.4

—

26.28

—

(3008898) HLA-B27 [Presence]

397

0.80

0.58

1.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

230

0.73

0.57

2.2

2.5

0.00

g/l

-0.00

215

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.49

0.57

1.1

1.0

—

0.46

—

(3003740) Influenza virus B Ag [Presence] in Specimen

229

1.27

0.57

1.3

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.49

0.57

1.2

—

43.20

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

149

1359

1.11

0.56

1.8

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

135

1483

0.90

0.55

3.1

2.8

1.15

0.93

e6/l

0.37

744

(3040151) Glucose [Moles/volume] in Capillary blood

1.45

0.55

1.4

5.2

8.05

7.23

mmol/l

0.17

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

557

0.84

0.55

1.0

1.2

0.87

0.91

g/l

0.58

557

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

590

1.16

0.55

2.1

2.8

89.61

155.12

ng/l

2.30

531

(3003888) Timothy IgE Ab [Units/volume] in Serum

177

1.31

0.55

1.2

1.1

0.82

5.57

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.58

0.54

2.2

3.3

0.50

1.50

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

555

0.84

0.53

10.9

11.9

0.66

0.62

0.25

550

(3002582) Erythrocytes [#/volume] in Urine

291

2748

1.08

0.53

3.6

3.1

36.83

74.00

e6/l

0.77

239

2057

(3018095) Leukocytes [#/volume] in Urine

336

3191

1.08

0.53

3.9

3.7

73.13

87.27

e6/l

0.22

259

2211

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.54

0.53

1.0

1.8

114.83

139.87

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

126

1144

1.12

0.53

7.2

6.2

1.04

1.02

mmol/l

0.42

119

1068

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

543

0.84

0.52

1.0

1.1

1.48

1.50

g/l

0.29

543

(3004119) Hemoglobin [Mass/volume] in Venous blood

543

0.84

0.52

2.9

2.8

133.22

132.42

g/l

0.09

532

(3037121) Protein [Mass/volume] in Urine

304

0.78

0.52

3.3

3.9

672.00

438.38

mg/l

0.31

143

(44806420) Estimation of glomerular filtration rate

117

1.37

0.52

2.8

2.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.62

0.52

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.61

0.52

2.3

4.1

—

(3045142) Bone marrow Pathology biopsy report

0.61

0.52

1.7

1.2

—

(40758558) Short blood count panel - Blood

286

2705

1.08

0.50

6.4

6.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

234

1.25

0.50

1.2

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

155

1429

1.10

0.49

2.4

2.6

13.69

14.00

umol/l

0.21

137

1337

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.40

0.48

1.2

—

74.78

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

208

1.26

0.48

1.4

11.82

13.68

e6/l

0.09

152

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

636

1.14

0.47

3.3

4.2

78.17

80.62

ng/l

0.11

566

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.62

0.46

1.0

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.61

0.46

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.61

0.46

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

283

1.21

0.45

1.1

—

(4195642) Thrombophilia screening test

147

1.30

0.45

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.59

0.45

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.59

0.45

1.6

2.4

1.19

mmol/l

—

(3035285) Chloride [Moles/volume] in Venous blood

0.59

0.45

1.6

2.4

107.60

105.49

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

0.59

0.45

1.6

2.4

3.92

4.02

mmol/l

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.59

0.45

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

156

1.29

0.45

1.0

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

124

1350

0.91

0.45

3.3

2.9

3.38

2.06

e6/l

0.66

615

(3042936) Bacteria identified in Isolate by Culture

139

1282

1.10

0.45

1.9

2.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.38

0.44

1.6

1.3

—

85.00

—

(3007853) Bacteria identified in Skin by Aerobe culture

115

1052

1.10

0.44

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

249

2358

1.07

0.43

1.8

1.7

19.91

20.31

nmol/l

0.17

205

2030

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

852

1.11

0.43

1.8

2.4

0.21

0.22

g/l

0.75

801

(3004451) EKG impression Narrative

1.43

0.42

1.6

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.43

0.42

1.1

1.2

1.08

1.06

ratio

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

286

1.20

0.42

2.3

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.40

0.0

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.47

0.40

1.4

1.2

0.35

0.28

g/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

1.6

2.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

214

1.22

0.39

1.5

1.4

793.00

533.04

e6/l

0.12

162

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.31

0.39

1.0

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.43

0.39

1.0

1.3

120.20

103.21

—

(3028026) IgM [Mass/volume] in Serum or Plasma

599

1.13

0.39

2.2

1.7

1.63

1.24

g/l

0.44

557

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

111

1021

1.10

0.39

1.6

1.8

—

(3023419) Bacteria identified in Sputum by Culture

124

1.29

0.38

4.3

2.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

289

1.18

0.38

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.39

0.38

1.4

1.3

6.32

6.37

mmol/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.35

0.38

1.5

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

393

3794

1.06

0.37

2.0

99.85

96.84

pmol/l

0.58

209

2050

(40768806) Pleura Pathology biopsy report

1.33

0.37

1.1

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

246

0.81

0.37

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

245

0.81

0.36

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

701

0.89

0.36

2.4

2.2

5.65

7.52

ug/l

0.71

636

(3025941) Bacteria identified in Stool by Culture

489

1.13

0.36

1.4

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1.34

0.36

2.1

2.4

29.50

20.86

mg/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

367

3542

1.06

0.35

4.6

4.3

1.88

1.83

ug/l

0.06

341

3270

(3018333) Ribosomal P Ab [Presence] in Serum

0.62

0.35

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

244

2556

0.94

0.35

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

244

0.82

0.35

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.40

0.35

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

447

0.87

0.35

1.1

—

0.97

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

255

2439

1.06

0.34

2.8

3.0

796.32

1046.30

ng/l

0.90

219

2023

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

128

1368

0.93

0.33

2.0

2.2

3.59

3.66

ratio

0.24

101

1095

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.70

0.33

1.2

—

(3005570) Glucose [Moles/volume] in Urine

0.67

0.33

1.0

2.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.66

0.33

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

423

0.87

0.32

3.8

3.7

47.23

48.29

0.10

418

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

248

1.17

0.32

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

110

1.28

0.31

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

561

1.11

0.31

2.1

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

186

0.80

0.31

1.3

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

290

2792

1.05

0.31

2.3

—

(3045788) Cell count panel - Pleural fluid

1.27

0.30

1.3

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

727

1.09

0.30

1.4

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1042

0.92

0.29

1.8

3.49

3.52

mmol/l

0.10

762

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

260

1.16

0.29

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

109

0.73

0.29

1.0

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

195

0.82

0.29

2.4

2.9

2.04

1.58

mmol/l

0.61

190

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

279

1.15

0.29

1.5

1.4

—

(3011648) Oxygen content in Venous blood

103

1.27

0.28

1.3

1.8

9.99

11.24

0.42

103

(3000475) Leukocytes [#/volume] in Synovial fluid

237

0.84

0.28

1.3

1.7

8700.20

12138.58

e6/l

0.33

162

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.27

0.27

1.5

1.4

5.17

6.06

u/l

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

164

1724

0.94

0.27

4.5

3.8

195.52

481.89

ng/l

2.12

122

1311

(44806118) Parainfluenza type 4 nucleic acid detection

119

0.75

0.27

1.0

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

119

0.75

0.27

1.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

119

0.75

0.27

1.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

119

0.75

0.27

1.0

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

113

1.24

0.26

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.70

0.26

1.8

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.69

0.26

2.4

2.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

341

0.88

0.26

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

288

0.86

0.26

1.5

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

277

2862

0.96

0.25

3.9

3.7

21.72

21.41

0.12

108

1113

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

130

1232

1.06

0.25

2.4

2.6

23.70

23.63

0.02

112

1153

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

198

1.17

0.24

2.8

2.4

297.58

104.27

ug/min

0.41

120

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

142

1.20

0.24

1.2

1.1

7.88

2.02

eliau/ml

0.44

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

629

1.09

0.24

1.1

1.3

41.28

46.08

au/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.27

0.24

1.7

1.2

3.82

2.80

u/ml

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.17

0.24

1.3

1.4

7.22

6.14

mmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

312

1.13

0.24

1.6

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.70

0.24

1.3

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

418

4086

1.04

0.23

2.6

—

estimate

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

473

0.91

0.23

2.9

2.4

0.55

0.61

0.85

473

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.24

0.23

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.24

0.23

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.23

1.2

1.3

10.52

8.44

ug/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.77

0.22

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

157

0.83

0.22

1.6

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

153

1.18

0.22

1.1

1.5

0.22

0.31

nmol/l

0.72

113

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

189

0.84

0.22

1.4

1.2

234.49

254.64

u/ml

—

116

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.74

0.22

1.4

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

146

0.82

0.22

1.8

3.0

—

8.17

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

129

1228

1.06

0.22

1.4

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

691

1.08

0.22

2.8

3.0

76.36

72.29

e9/l

0.32

505

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.19

0.21

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.19

0.21

1.8

2.7

21.22

207.75

ug/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

6.26

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.21

0.0

3.9

—

0.23

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

38.80

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

3.2

—

(3002256) Pathology report gross observation

121

1151

1.06

0.21

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

240

2324

1.04

0.21

3.9

4.2

91.68

92.24

0.13

232

2283

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.23

0.21

1.3

1.4

—

(44806071) Cardiolipin IgM antibody measurement

0.00

0.21

0.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

103

0.77

0.21

1.4

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

356

0.90

0.21

4.7

3.3

25.00

25.16

mmol/l

0.09

346

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

59.08

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

51.88

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.6

—

(3025130) Human papilloma virus identified in Specimen

123

0.81

0.20

1.8

—

(40757373) Influenza virus identified in Isolate

0.00

0.20

0.0

2.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

774

7664

1.04

0.20

18.3

17.8

13.56

13.53

0.27

768

7579

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.20

0.19

10.0

7.0

4.86

330.18

ug/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.20

0.19

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

231

1.13

0.19

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

337

1.10

0.19

1.3

1.7

236.00

270.95

mu/l

0.76

314

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

118

1.19

0.19

1.1

1.4

140.40

234.56

pmol/l

0.59

118

(3011397) Hemoglobin [Presence] in Urine by Test strip

201

2077

0.96

0.19

3.2

3.5

—

0.17

—

(4034850) Laboratory test

280

1.11

0.18

9.5

—

(3000492) Spirometry study

119

1138

1.05

0.18

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

290

1.11

0.18

2.1

2.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.21

0.18

1.1

1.0

—

1.12

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

223

1.12

0.18

2.2

2.1

6092.12

1443.13

u/l

0.35

(44816559) Phosphatidylethanol [Mass/volume] in Blood

507

0.92

0.18

1.6

1.8

0.29

0.35

mg/l

0.34

272

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

215

2215

0.96

0.18

2.9

2.8

0.70

0.68

ug/l

0.13

118

1181

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.15

0.17

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.13

0.17

1.1

1.2

—

(40768793) Breast Pathology biopsy report

205

1.12

0.17

1.2

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.11

0.17

2.6

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.76

0.17

1.0

1.1

—

1.22

—

(3000991) Gas panel - Venous blood

751

0.94

0.16

9.5

10.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.71

0.16

1.4

1.1

93.40

110.63

pmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.71

0.16

1.4

2.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

138

1329

1.04

0.16

2.3

2.6

2.39

2.35

g/l

0.30

121

1237

(3026008) Bacteria identified in Urine by Culture

227

2209

1.04

0.16

3.2

2.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

177

1.13

0.16

1.4

1.2

11.58

29.51

u/l

1.54

149

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

139

1.15

0.16

1.1

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.13

0.16

1.0

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

907

1.05

0.16

2.7

1.82

1.79

0.09

818

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

467

1.07

0.16

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

206

1.12

0.16

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

994

0.95

0.16

7.6

9.1

0.50

0.89

mmol/l

0.62

825

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

683

1.06

0.15

2.1

2.4

13.96

19.04

au/ml

—

(40768800) Prostate Pathology biopsy report

182

0.88

0.15

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

102

1.18

0.15

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

244

0.90

0.14

2.2

2.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

401

1.08

0.14

1.3

1.9

8.93

7.59

iu/ml

—

(4281824) Cell count and differential, peritoneal fluid

0.79

0.14

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

150

1.14

0.14

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

150

1.14

0.14

1.6

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

112

1.16

0.14

1.2

—

83.63

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

179

1.12

0.14

1.5

154.38

156.25

au/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

160

1.13

0.14

1.1

1.2

1.17

2.70

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

295

1.09

0.14

1.1

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.19

0.14

1.5

1.6

35.94

32.26

g/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

103

1.17

0.13

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

103

1.17

0.13

1.2

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

1.17

0.13

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.82

0.13

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

142

1.13

0.12

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

580

1.05

0.12

1.7

—

(21494755) Public health laboratory ask at order entry panel

129

1251

1.04

0.12

1.4

—

(3047181) Lactate [Moles/volume] in Blood

261

0.92

0.11

4.8

6.5

1.26

1.28

mmol/l

0.05

228

(3019832) Treponema pallidum Ab [Presence] in Serum

639

0.95

0.11

2.1

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

207

2112

0.98

0.10

2.1

2.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.14

0.10

2.2

1.5

154.40

81.53

ng/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

154

1576

0.97

0.10

2.2

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

1.4

—

0.42

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

106

1090

0.97

0.09

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

311

1.06

0.09

1.7

2.3

2.63

2.91

g/l

0.96

285

(3014148) Varicella zoster virus Ab [Titer] in Serum

126

1.11

0.09

1.1

1.2

—

(3020891) Body temperature

390

0.95

0.09

3.5

4.1

36.89

36.92

°c

0.20

385

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.09

0.09

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

195

1.08

0.08

1.7

1.4

—

(3012441) Differential panel - Pleural fluid

1.06

0.08

1.4

1.5

—

(40768441) Liver Pathology biopsy report

0.84

0.07

1.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.08

0.07

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

619

1.04

0.07

1.2

124.12

138.82

u/ml

0.12

246

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

442

1.04

0.07

1.9

3.0

74.48

69.70

u/ml

0.03

429

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.07

0.07

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

118

1.10

0.07

1.2

1.4

—

nmol/l

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

122

0.90

0.07

1.3

2.6

—

1980.00

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

631

1.03

0.06

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

101

988

1.02

0.06

6.1

6.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

142

0.91

0.06

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

101

0.89

0.06

1.1

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

166

1635

1.02

0.06

2.5

2.9

2.44

mmol/l

0.15

154

1483

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

484

1.03

0.05

1.6

—

(3019977) pH of Arterial blood

1000

0.98

0.05

7.5

9.2

7.43

7.41

1.43

547

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

859

0.98

0.05

4.2

4.5

22.29

26.09

ug/l

0.07

693

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

435

1.04

0.05

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

298

1.04

0.04

1.5

1.24

1.21

g/l

0.20

283

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

231

0.95

0.04

3.1

2.9

0.29

0.36

iu/ml

0.42

118

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

159

0.94

0.03

1.1

1.2

2.30

3.44

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

128

0.94

0.02

1.4

1.3

7.38

6.95

mmol/l

0.20

112

(3019150) Specific gravity of Urine by Refractometry

205

2063

0.99

0.02

3.5

3.6

1.02

1.76

kg/l

0.50

136

1365

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

1.04

0.02

1.1

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

105

1060

0.99

0.02

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

218

2170

1.01

0.01

1.8

0.92

1.10

mg/l

0.57

158

1686

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

114

1.05

0.00

1.1

110.25

101.11

0.50

108

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

136

0.96

0.00

1.2

1.5

0.59

13.88

nmol/l

0.50

128

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

164

1.04

0.00

3.8

2.6

—

302.88

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

284

1.02

0.00

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

446

0.99

0.00

1.7

1.4

—

(36660697) Celiac disease serology panel - Serum

726

0.99

0.00

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

1.03

0.00

1.7

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

136

1.03

0.00

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

176

1.02

0.00

1.1

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

226

1.02

0.00

2.0

3.2

0.83

1.74

index

0.94

124

(3050129) First trimester maternal screen panel - Serum or Plasma

118

1.02

0.00

1.6

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

252

0.99

0.00

2.0

1.9

3.26

4.12

iu/l

0.36

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1.00

0.00

1.7

2.2

4.30

4.31

g/l

0.04

303

(3039443) Prostate specific Ag panel - Serum or Plasma

339

1.00

0.00

1.5

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1.00

0.00

1.7

2.2

7.58

7.21

g/l

0.78

303

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1.00

0.00

1.7

2.2

3.56

3.80

g/l

0.53

303

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

291

1.00

0.00

1.4

1.5

0.27

0.24

g/l

1.06

276

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

123

0.98

0.00

1.2

1.4

0.17

0.34

nmol/l

—

(3044941) Cell count panel - Synovial fluid

169

1.01

0.00

1.1

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

983

1.00

0.00

1.7

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

773

1.00

0.00

8.7

7.6

9.23

9.02

mmol/l

0.09

740

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

145

1.03

0.00

2.4

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

185

0.97

0.00

1.3

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

195

1.03

0.00

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

1.03

0.00

1.2

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.0

4.9

—

4.92

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

348.00

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

9.85

—

(3013762) Body weight Measured

0.00

0.0

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

4.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

0.02

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.1

—

13.00

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

191.88

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

67.39

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.91

-0.00

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.4

1.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.52

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.91

-0.00

1.3

1.1

—

(3001729) Color of Synovial fluid

0.00

-0.00

0.0

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(44813793) Dust mix specific IgE antibody measurement

0.91

-0.00

1.2

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.4

1.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

16.17

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.4

1.9

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

1363.40

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.95

-0.00

1.3

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

588.00

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.60

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

6.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

0.44

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.02

-0.00

1.7

1.2

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.95

-0.00

1.1

1.5

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

15.95

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

6.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_MUMPS_WIDE – Mumps, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mumps, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Mumps, including avohilmo (AB1_MUMPS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints